Clinical Trials
Braintumor Website

There are 12 trials:
Facility: Ann & Robert H. Lurie Children's Hospital of Chicago
NCT Trial Name# of Centers

NCT01356290

  Metronomic and Targeted Anti-angiogenesis Therapy for Children With Recurrent/Progressive Medulloblastoma
17

NCT01734512

  PNOC 001: Phase II Study of Everolimus for Recurrent or Progressive Low-grade Gliomas in Children
14

NCT01748149

  Vemurafenib in Children With Recurrent/Refractory BRAFV600E-mutant Gliomas
14

NCT02960230

  H3.3K27M Peptide Vaccine for Children With Newly Diagnosed DIPG and Other Gliomas
11

NCT02717455

  Trial of Panobinostat in Children With Diffuse Intrinsic Pontine Glioma
10

NCT02962167

  Modified Measles Virus (MV-NIS) for Children and Young Adults With Recurrent Medulloblastoma or Recurrent ATRT
6

NCT02274987

  Molecular Profiling for Individualized Treatment Plan for DIPG
5

NCT00890786

  A Study of Bevacizumab Therapy in Patients With Newly Diagnosed High-Grade Gliomas and Diffuse Intrinsic Pontine Gliomas
2

NCT01595126

  Longitudinal Study of Biomarkers
1

NCT01595139

  MicroRNAs in Patients With Neurofibromatosis Type 1
1

NCT01541800

  Circulating microRNAs as Disease Markers in Pediatric Cancers
1

NCT02722512

  Trial of Heat Shock Protein Peptide Complex-96 (HSPPC-96) Vaccine
1



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2018 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740


Website Design By
World Wide Websites